Fraunhofer USA, Inc.
 
 
 
 
 Fraunhofer-Gesellschaft

 

 

 

 

 

 

 

 

 

 

 

Fraunhofer Center for Molecular Biotechnology (CMB)

A Strategy to Neutralize the Threat of Bioterrorism


We have new technology for safer vaccine development that will soon lead the way to protection for the entire U.S. population from bioterrorism threats. Public health benefits will accrue, as well. This new technology is cheaper, safer and takes much less production time than current practices. It's a particular type of plant science known as Transient Gene Expression (TGE).

 

Business Areas

Our core platform technologies are employed in the following business areas to help partners effectively and efficiently meet their protein production needs:

Vaccines
Transient gene expression provide a particularly effective modality for developing vaccines used in the prevention and treatment of diseases, including applications for anti-bioterrorism. 

Protein Therapeutics
Molecular farming offers a safer and less expensive means of producing monoclonal antibodies (Mabs) while eliminating the risk of contamination by animal pathogens, with low investment scale-up.

Industrial Enzymes
Molecular farming stimulates higher yield and significantly reduces the costs associated with industrial biocatalysis; while directed evolution allows improvement of enzyme function.

Ag Biotech
Transient gene expression helps define the function of new genes and can be used to alter the metabolism of plants for the production of desired metabolites.

 

Contact Information:

Fraunhofer Center for Molecular Biotechnology

9 Innovation Way, Suite 200

Newark, Delaware 19711

 

Tel:  (302) 369-1708

Fax:  (302) 369 8952

 

http://www.fraunhofer-cmb.org/

Linking Policy
© 2008
Fraunhofer USA, Inc.